Methods for Novel Drug Discovery, Treatment And Selective Targeting for Gefitinib-Resistant Non-Small-Cell Lung Cancer Harboring T790M Mutation

• 收藏
• 分享

专利权人:

发明人:

Elaine Lai-Han LEUNG,Liang LIU,Xing-Xing FAN

申请号：

US14296477

公开号：

US20150297582A1

申请日:

2014.06.05

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The present invention relates to methods for novel drug discovery, treatment and selective targeting for Gefitinib-resistant non-small-cell lung cancer (NSCLC) harboring an additional mutation, in particular, to the discovery of a drug candidate or agent identified by the presently claimed method for use in treating and selective targeting Gefitinib-resistant NSCLC harboring T790M mutation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/